[1]
C. Munera, PhD, M. Drehobl, MD, N. E. Sessler, PharmD, and C. Landau, MD, “A randomized, placebo-controlled, double-blinded, parallel-group, 5-week study of buprenorphine transdermal system in adults with osteoarthritis”, J of Opioid Management, vol. 6, no. 3, pp. 193–202, Jan. 2018.